BTH

AU000000BTH6

Market Closed - Australian S.E. Other stock markets 06:59:59 13/09/2024 BST			5-day change	1st Jan Change
0.1200 ^AUD	+4.35%		+4.35%	-40.00%

08-29	Transcript : Bigtincan Holdings Limited, 2024 Earnings Call, Aug 29, 2024
08-29	Bigtincan Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2024	CI

Bigtincan Holdings Limited Provides Financial Results Outlook for Fiscal Year 2023

July 21, 2023 at 01:01 am

Bigtincan Holdings Limited provided financial results outlook for fiscal year 2023. For the period, the company expected revenue in the range of $123 million - 128 million.

Latest news about BIGN HLDG

Transcript : Bigtincan Holdings Limited, 2024 Earnings Call, Aug 29, 2024	08-29
Bigtincan Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2024	08-28	CI
Bigtincan Holdings Rejects Vector's Revised Acquisition Offer	06-20	MT
US Inflation, Policy Announcement Jitters Suppress Appetite for Australian Shares	06-12	MT
Bigtincan Holdings Says Non-Binding Indicative Offer from Vector Capital Withdrawn; Shares Down 18%	06-12	MT
Vector Capital Management, L.P. cancelled the acquisition of Bigtincan Holdings Limited.	06-11	CI
Bigtincan Holdings Receives AU$0.25 Per Share Acquisition Offer from Vector Capital Management	06-11	MT
Vector Capital Management, L.P. made an offer to acquire Bigtincan Holdings Limited for AUD 150 million.	06-10	CI
Bigtincan Holdings Limited Announces Executive Changes	06-03	CI
Bigtincan Holdings Logs AU$30 Million Revenue in Fiscal Q3; Shares Surge 19%	04-11	MT
Bigtincan Holdings Limited(ASX:BTH) dropped from S&P/ASX All Ordinaries Index	03-17	CI
Bigtincan Shares Shed 11% as Fiscal H1 Revenue Contracts 1.5%; Loss Narrows	02-28	MT
Transcript : Bigtincan Holdings Limited, H1 2024 Earnings Call, Feb 27, 2024	02-28
Bigtincan Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-27	CI
Transcript : Bigtincan Holdings Limited - Shareholder/Analyst Call	11-28
Bigtincan Holdings Limited Provides Earnings Guidance for the Fiscal Year 2024	11-14	CI
Bigtincan Holdings Limited Announces Resignation of Farouk Hussein as Non-Executive Director	03/10/23	CI
Bigtincan Holdings Limited(ASX:BTH) dropped from S&P Global BMI Index	18/09/23	CI
Bigtincan Reportedly Say It Remains in Takeover Talks	18/09/23	CI
Bigtincan Holdings Launches Cost Reduction Program	15/09/23	MT
Transcript : Bigtincan Holdings Limited, 2023 Earnings Call, Aug 30, 2023	31/08/23
Bigtincan Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2023	30/08/23	CI
Bigtincan to Borrow AU$15 Million to Grow AI Technology	21/07/23	MT
Bigtincan Holdings Limited Provides Financial Results Outlook for Fiscal Year 2023	21/07/23	CI
Transcript : Bigtincan Holdings Limited - Special Call	22/05/23

Beta Pharmaceutical Limited is a Australia-based biopharmaceutical company. The Company is focused on the identification, development and commercialization of products and therapies targeting the chemoprevention and treatment of breast cancer. The Company is working in collaboration with scientists at the College of Pharmacy, University of Louisiana at Monroe in southern the United States of America (ULM) to develop cancer chemopreventive agents using natural phytonutrients, called tocotrienols as treatments for breast cancers. Funded by Beta Pharmaceutical Limited, the applied research programme with ULM includes four laboratories and is known as the Breast Cancer and Health Project, which has been underway.

Employees

495

Sector

More about the company